BIOMAT Database Logo BIOMAT Database Logo

N-oxides of 9-(beta-D-xylofuranosyl)adenine and 9-(beta-D-arabinofuranosyl)adenine. 1967

E J Reist, and D F Calkins, and L Goodman

UI MeSH Term Description Entries
D010087 Oxides Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. Oxide
D002625 Chemistry, Organic The study of the structure, preparation, properties, and reactions of carbon compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Organic Chemistry
D002854 Chromatography, Paper An analytical technique for resolution of a chemical mixture into its component compounds. Compounds are separated on an adsorbent paper (stationary phase) by their varied degree of solubility/mobility in the eluting solvent (mobile phase). Paper Chromatography,Chromatographies, Paper,Paper Chromatographies
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001089 Arabinose L-Arabinose,L Arabinose
D014994 Xylose D-Xylose,D Xylose
D055601 Organic Chemistry Phenomena The conformation, properties, reaction processes, and the properties of the reactions of organic carbon compounds. Organic Chemistry Concepts,Organic Chemistry Processes,Organic Chemistry Phenomenon,Organic Chemistry Process,Chemistry Process, Organic,Chemistry Processes, Organic,Concept, Organic Chemistry,Concepts, Organic Chemistry,Organic Chemistry Concept,Phenomena, Organic Chemistry,Phenomenon, Organic Chemistry,Process, Organic Chemistry,Processes, Organic Chemistry

Related Publications

E J Reist, and D F Calkins, and L Goodman
Synthesis of sugar moiety substituted nucleosides. I. 9-[3-O-(n-hexyl)-alpha, beta-D-xylofuranosyl] adenine and 9-[3-O-(n-hexyl)-5-deoxy-alpha, beta-D-xylofuranosyl] adenine.
March 1970, Journal of pharmaceutical sciences,
E J Reist, and D F Calkins, and L Goodman
[Studies on pharmacokinetics of 9-beta-D-arabinofuranosyl adenine nanocapsules].
January 1992, Yao xue xue bao = Acta pharmaceutica Sinica,
E J Reist, and D F Calkins, and L Goodman
Synthesis and antiviral evaluation of 4'-alkoxy analogues of 9-(beta-D-xylofuranosyl)adenine.
January 2009, Antiviral chemistry & chemotherapy,
E J Reist, and D F Calkins, and L Goodman
Synthesis of 9-(2,3-dideoxy-2,3-difluoro-beta-D-arabinofuranosyl)adenine.
January 2007, Nucleosides, nucleotides & nucleic acids,
E J Reist, and D F Calkins, and L Goodman
Synthesis and biological evaluation of 9-(beta-L-arabinofuranosyl)adenine.
January 1999, Nucleosides & nucleotides,
E J Reist, and D F Calkins, and L Goodman
[Synthesis of modified oligodeoxyribonucleotides containing 9-(2'-amino-2'-deoxy-beta-D-arabinofuranosyl)adenine].
October 1997, Bioorganicheskaia khimiia,
E J Reist, and D F Calkins, and L Goodman
Synthesis of 9-(beta-D-arabinofuranosyl)adenine 5'-phosphate starting from adenosine 5'-phosphate.
August 1977, Chemical & pharmaceutical bulletin,
E J Reist, and D F Calkins, and L Goodman
Development of an intravenous formulation for the antiviral drug 9-(beta-D-arabinofuranosyl)-adenine.
January 1987, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
E J Reist, and D F Calkins, and L Goodman
Conformation of N(9)-(beta-D-arabinofuranosyl) adenine 5'-monophosphate (ara-AMP) in anhydrous dimethylsulphoxide monitored by 13C NMR.
July 1982, FEBS letters,
E J Reist, and D F Calkins, and L Goodman
[Inhibiting action of 9-beta-D-xylofuranosyl-adenine on the multiplication of herpes virus in cell culture].
January 1967, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
Copied contents to your clipboard!